Jeffrey B. Geske

7.3k total citations · 2 hit papers
203 papers, 4.1k citations indexed

About

Jeffrey B. Geske is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Jeffrey B. Geske has authored 203 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Cardiology and Cardiovascular Medicine, 56 papers in Epidemiology and 49 papers in Surgery. Recurrent topics in Jeffrey B. Geske's work include Cardiomyopathy and Myosin Studies (140 papers), Cardiovascular Function and Risk Factors (83 papers) and Cardiovascular Effects of Exercise (49 papers). Jeffrey B. Geske is often cited by papers focused on Cardiomyopathy and Myosin Studies (140 papers), Cardiovascular Function and Risk Factors (83 papers) and Cardiovascular Effects of Exercise (49 papers). Jeffrey B. Geske collaborates with scholars based in United States, Canada and Belarus. Jeffrey B. Geske's co-authors include Steve R. Ommen, Rick A. Nishimura, Bernard J. Gersh, Paul Sorajja, Hartzell V. Schaff, Konstantinos C. Siontis, Joseph A. Dearani, Michael J. Ackerman, Kevin Ong and Sean B. Smith and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Jeffrey B. Geske

184 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Detection of Hypertrophic Cardiomyopathy Using a Convolutional Neural Network-Enabled Electrocardiogram

2020 242 citations Konstantinos C. Siontis, Steve R. Ommen et al. profile →
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy

2022 183 citations Milind Y. Desai, Anjali Owens et al. profile →

Peers

Countries citing papers authored by Jeffrey B. Geske

Since Specialization

Citations

This map shows the geographic impact of Jeffrey B. Geske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey B. Geske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey B. Geske more than expected).

Fields of papers citing papers by Jeffrey B. Geske

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey B. Geske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey B. Geske. The network helps show where Jeffrey B. Geske may publish in the future.

Co-authorship network of co-authors of Jeffrey B. Geske

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey B. Geske. A scholar is included among the top collaborators of Jeffrey B. Geske based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey B. Geske. Jeffrey B. Geske is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcomes of septal myectomy in patients with obstructive hypertrophic cardiomyopathy and minimal septal hypertrophy 2025 ·Journal of Thoracic and Cardiovascular Surgery ·(unknown), Hartzell V. Schaff, (unknown), (unknown), Austin Todd, Steve R. Ommen, Joseph A. Dearani, Gabor Bagameri, Jeffrey B. Geske	1
2	Clinical Implications of Left Ventricular Apex Mechanics in Patients With Apical Hypertrophic Cardiomyopathy 2024 ·Journal of the American Society of Echocardiography ·(unknown), Wei Zhou, Jeffrey B. Geske, (unknown), Jie Tian, Shiliang Liu, Hui Wang, Xueqing Chen, (unknown), Youbin Deng, Yani Liu	3
3	Rethinking Risk in Hypertrophic Cardiomyopathy: Assessing the Role of Myocardial Fibrosis and Left Ventricular Hypertrophy in Sudden Cardiac Death 2024 ·SHILAP Revista de lepidopterología ·(unknown), Juan Farina, (unknown), (unknown), Michael O’Shea, (unknown), (unknown), Jeffrey B. Geske, Konstantinos C. Siontis, Said Alsidawi	0
4	Invasive Cardiac Hemodynamics in Apical Hypertrophic Cardiomyopathy 2024 ·Journal of the American Heart Association ·(unknown), (unknown), William R. Miranda, (unknown), Christopher G. Scott, (unknown), Adelaide M. Arruda‐Olson, Jeffrey B. Geske, Kyle W. Klarich, (unknown)	1
5	Tricuspid valve surgery following septal myectomy in patients with a cardiac implantable electronic device 2024 ·JTCVS Open ·(unknown), Hartzell V. Schaff, Jeffrey B. Geske, Joseph A. Dearani, Steve R. Ommen	0
6	Clinical features and postoperative outcomes in elderly patients undergoing septal myectomy for hypertrophic cardiomyopathy 2024 ·Journal of Thoracic and Cardiovascular Surgery ·(unknown), Hartzell V. Schaff, Fernando M. Juarez-Casso, (unknown), Austin Todd, Joseph A. Dearani, Gabor Bagameri, Steve R. Ommen, Jeffrey B. Geske	1
7	Outcomes of surgical septal myectomy for obstructive hypertrophic cardiomyopathy after previous septal reduction therapy 2024 ·Journal of Thoracic and Cardiovascular Surgery ·(unknown), Hartzell V. Schaff, (unknown), Hao Cui, Joseph A. Dearani, Jeffrey B. Geske, Mackram F. Eleid, Alexander T. Lee, Brian D. Lahr, Steve R. Ommen	1
8	Sex‐Related Differences in Patients With Hypertrophic Cardiomyopathy Undergoing Alcohol Septal Ablation 2024 ·Journal of the American Heart Association ·(unknown), (unknown), Jeffrey B. Geske, Kyle W. Klarich, Mayra Guerrero, Mackram F. Eleid	0
9	Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM 2024 ·Circulation ·Milind Y. Desai, Kathy Wolski, Anjali Owens, Jeffrey B. Geske, Sara Saberi, Andrew Wang, Mark V. Sherrid, Paul Cremer, Neal K. Lakdawala, Albree Tower‐Rader, David Fermin, Srihari S. Naidu, Nicholas G. Smedira, Hartzell V. Schaff, (unknown), (unknown), Kathy Lampl, Amy J. Sehnert, Steven E. Nissen, (unknown)	14
10	Determining the cause of cardiac arrest: artificial intelligence at the bedside 2023 ·European Heart Journal - Digital Health ·(unknown), Jeffrey B. Geske, Konstantinos C. Siontis	1
11	ARRHYTHMIC SUDDEN DEATH SURVIVAL PREDICTION MODEL FOR HYPERTROPHIC CARDIOMYOPATHY PATIENTS: AN INTERPRETABLE MACHINE LEARNING ANALYSIS 2023 ·(unknown), Moein Enayati, (unknown), (unknown), Christopher G. Scott, Konstantinos C. Siontis, (unknown), Jeffrey B. Geske, Michael J. Ackerman, Adelaide M. Arruda‐Olson	1
12	Ultrasound Enhancing Agents with Transthoracic Echocardiography for Maximal Wall Thickness in Hypertrophic Cardiomyopathy 2023 ·SHILAP Revista de lepidopterología ·John P. Bois, Chadi Ayoub, Jeffrey B. Geske, Yee Weng Wong, Muhannad Abbasi, Thomas A. Foley, Sharon L. Mulvagh, Christopher G. Scott, Steve R. Ommen, Patricia A. Pellikka	0
13	Hemodynamic Predictors of Outcome Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy 2023 ·Circulation Cardiovascular Interventions ·(unknown), (unknown), Rick A. Nishimura, William R. Miranda, Jeffrey B. Geske, Charanjit S. Rihal, Mackram F. Eleid	4
14	Aortic valve regurgitation following transaortic septal myectomy for obstructive hypertrophic cardiomyopathy: Incidence and influence on late outcomes 2023 ·Journal of Thoracic and Cardiovascular Surgery ·Fernando M. Juarez-Casso, Hartzell V. Schaff, Sri Harsha Patlolla, Austin Todd, Joseph A. Dearani, Jeffrey B. Geske, Steve R. Ommen, Rick A. Nishimura	1
15	High-Sensitivity Cardiac Troponin T Elevation in Hypertrophic Cardiomyopathy Is Associated With Ventricular Arrhythmias 2023 ·Mayo Clinic Proceedings ·(unknown), Darrell B. Newman, Allan S. Jaffe, Michael J. Ackerman, Steve R. Ommen, Jeffrey B. Geske	4
16	Arrhythmia Monitoring for Risk Stratification in Hypertrophic Cardiomyopathy 2022 ·CJC Open ·(unknown), (unknown), Kevin Ong, (unknown), Adaya Weissler‐Snir, Jeffrey B. Geske, Zachary Laksman	7
17	Impact of Race and Ethnicity on Use and Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy 2022 ·Journal of the American Heart Association ·Sri Harsha Patlolla, Hartzell V. Schaff, Rick A. Nishimura, Mackram F. Eleid, Jeffrey B. Geske, Steve R. Ommen	6
18	Deep Neural Network for Cardiac Magnetic Resonance Image Segmentation 2022 ·Journal of Imaging ·David Chen, (unknown), Nakeya Dewaswala, Shivaram P. Arunachalam, Moein Enayati, (unknown), Kalyan S. Pasupathy, (unknown), J. Martijn Bos, Peter A. Noseworthy, Reza Arsanjani, Bradley J. Erickson, Jeffrey B. Geske, Michael J. Ackerman, Philip A. Araoz, Adelaide M. Arruda‐Olson	8
19	Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks 2022 ·Circulation ·Milind Y. Desai, Anjali Owens, Jeffrey B. Geske, Kathy Wolski, Sara Saberi, Andrew Wang, Mark V. Sherrid, Paul Cremer, Srihari S. Naidu, Nicholas G. Smedira, Hartzell V. Schaff, Ellen McErlean, Christina Sewell, Aarthi Balasubramanyam, Kathy Lampl, Amy J. Sehnert, Steven E. Nissen	53
20	Interventional Imaging for Structural Heart Disease: Challenges and New Frontiers of an Emerging Multi-disciplinary Field 2019 ·Structural Heart ·Dee Dee Wang, Jeffrey B. Geske, Andrew Choi, James Lee, Omar Khalique, Sameer Gafoor, Kimberly Atianzar, Phillip Blanke, Stephen H. Little, Paul Sorajja, William W. O’Neill, João L. Cavalcante	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact